[Paid Post: Hong Kong Science and Technology Parks Corporation]
Global cancer deaths rose by 3.6 per cent over 10 years to 9.6 million – one in six of all fatalities – in 2018. Two groundbreaking Hong Kong biopharmaceutical companies are improving treatments by developing drugs that clinical tests show are potentially more effective and have fewer toxic side effects than typical chemotherapy. Athenex’s oral alternative to the intravenous drug, paclitaxel, can be taken safely at home and is less poisonous to patients. Bio-Cancer Treatment International’s drug helps to kill tumours by removing from the body an amino acid that leukaemia, melanoma and prostate cancer relies on to grow.
Full story: https://sc.mp/liot3

#Ad #HKSTP #cancertreatment #Athenex #BCT

Subscribe to our YouTube channel for free here: https://sc.mp/subscribe-youtube

Follow us on:
Website: https://scmp.com
Facebook: https://facebook.com/scmp
Twitter: https://twitter.com/scmpnews
Instagram: https://instagram.com/scmpnews
Linkedin: https://www.linkedin.com/company/south-china-morning-post/